At the news
? MIXEDIMPACT 6/10 8-K filed May 5, 2026 at 16:08 ET
Solventum reported Q1 2026 adjusted EPS of $1.48, beating consensus of $1.35 by 9.6%, and affirmed full-year guidance with EPS expected toward the high end of $6.40-$6.60. However, reported revenue declined 3.0% YoY to $2.007B due to the divestiture of Purification and Filtration, while organic sales grew 2.1%. GAAP EPS collapsed to $0.07 from $0.78 due to separation and restructuring costs, and free cash flow was deeply negative at $(273)M, reflecting seasonal and transition outflows.
- Q1 2026 net sales $2.007B, down 3.0% reported but up 2.1% organically
- Adjusted diluted EPS $1.48, +10.6% YoY, vs consensus $1.35
- GAAP diluted EPS $0.07, down 91% YoY due to separation/restructuring costs
- FY2026 guidance affirmed: organic sales growth +2-3%, adjusted EPS toward high end of $6.40-$6.60, FCF $200M
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access